{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:07:48Z","timestamp":1765357668072,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Public Welfare Science and Technology Project of Wenzhou","award":["Y20240077","Y20240077","Y20240077","Y20240077","Y20240077","Y20240077"],"award-info":[{"award-number":["Y20240077","Y20240077","Y20240077","Y20240077","Y20240077","Y20240077"]}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["No. LQ19H080002"],"award-info":[{"award-number":["No. LQ19H080002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-024-01728-5","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T17:03:00Z","timestamp":1724778180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mendelian randomization analysis reveals the combined effects of epigenetics and telomere biology in hematologic cancers"],"prefix":"10.1186","volume":"16","author":[{"given":"Xin","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"1728_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-med-042921-112347","volume":"74","author":"H Ahmad","year":"2023","unstructured":"Ahmad H, Jahn N, Jaiswal S. Clonal hematopoiesis and its impact on human health. Annu Rev Med. 2023;74:249\u201360.","journal-title":"Annu Rev Med"},{"issue":"26","key":"1728_CR2","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1056\/NEJMoa2300503","volume":"388","author":"EA DeBoy","year":"2023","unstructured":"DeBoy EA, Tassia MG, Schratz KE, et al. Familial clonal hematopoiesis in a long telomere syndrome. N Engl J Med. 2023;388(26):2422\u201333.","journal-title":"N Engl J Med"},{"issue":"9","key":"1728_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/cells8091050","volume":"8","author":"MI Vaquero-Sedas","year":"2019","unstructured":"Vaquero-Sedas MI, Vega-Palas MA. Assessing the epigenetic status of human telomeres. Cells. 2019;8(9):63.","journal-title":"Cells."},{"issue":"1","key":"1728_CR4","doi-asserted-by":"publisher","first-page":"195007","DOI":"10.1016\/j.bbagrm.2024.195007","volume":"1867","author":"A Das","year":"2024","unstructured":"Das A, Giri AK, Bhattacharjee P. Targeting \u201chistone mark\u201d: advanced approaches in epigenetic regulation of telomere dynamics in cancer. Biochim Biophys Acta Gene Regul Mech. 2024;1867(1):195007.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"2","key":"1728_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cbf.3687","volume":"40","author":"A Rafat","year":"2022","unstructured":"Rafat A, Dizaji Asl K, Mazloumi Z, et al. Telomerase-based therapies in haematological malignancies. Cell Biochem Funct. 2022;40(2):199\u2013212.","journal-title":"Cell Biochem Funct"},{"issue":"6","key":"1728_CR6","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.21873\/invivo.12142","volume":"34","author":"BMD Nogueira","year":"2020","unstructured":"Nogueira BMD, Machado CB, Montenegro RC, et al. Telomere Length and Hematological Disorders: A Review. In Vivo. 2020;34(6):3093\u2013101.","journal-title":"In Vivo"},{"issue":"1","key":"1728_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13148-019-0656-7","volume":"11","author":"PD Fransquet","year":"2019","unstructured":"Fransquet PD, Wrigglesworth J, Woods RL, et al. The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis. Clin Epigenetics. 2019;11(1):62.","journal-title":"Clin Epigenetics"},{"key":"1728_CR8","first-page":"11","volume":"5","author":"F Morales Berstein","year":"2022","unstructured":"Morales Berstein F, McCartney DL, Lu AT, et al. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study. Elife. 2022;5:11.","journal-title":"Elife."},{"issue":"1","key":"1728_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13059-021-02398-9","volume":"22","author":"DL McCartney","year":"2021","unstructured":"McCartney DL, Min JL, Richmond RC, et al. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging. Genome Biol. 2021;22(1):194.","journal-title":"Genome Biol"},{"issue":"2","key":"1728_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","volume":"49","author":"G Hannum","year":"2013","unstructured":"Hannum G, Guinney J, Zhao L, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359\u201367.","journal-title":"Mol Cell"},{"issue":"12","key":"1728_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.18632\/aging.100859","volume":"7","author":"S Horvath","year":"2015","unstructured":"Horvath S, Ritz BR. Increased epigenetic age and granulocyte counts in the blood of Parkinson\u2019s disease patients. Aging (Albany NY). 2015;7(12):1130\u201342.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"1728_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18632\/aging.101684","volume":"11","author":"AT Lu","year":"2019","unstructured":"Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303\u201327.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"1728_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","volume":"10","author":"ME Levine","year":"2018","unstructured":"Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573\u201391.","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"1728_CR14","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.","journal-title":"Genome Biol"},{"issue":"10","key":"1728_CR15","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41588-021-00944-6","volume":"53","author":"V Codd","year":"2021","unstructured":"Codd V, Wang Q, Allara E, et al. Polygenic basis and biomedical consequences of telomere length variation. Nat Genet. 2021;53(10):1425\u201333.","journal-title":"Nat Genet"},{"key":"1728_CR16","doi-asserted-by":"publisher","first-page":"e70382","DOI":"10.7554\/eLife.70382","volume":"11","author":"M Chong","year":"2022","unstructured":"Chong M, Mohammadi-Shemirani P, Perrot N, et al. GWAS and ExWAS of blood mitochondrial DNA copy number identifies 71 loci and highlights a potential causal role in dementia. Elife. 2022;11:e70382.","journal-title":"Elife"},{"issue":"3","key":"1728_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41588-018-0047-6","volume":"50","author":"M Kanai","year":"2018","unstructured":"Kanai M, Akiyama M, Takahashi A, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet. 2018;50(3):390\u2013400.","journal-title":"Nat Genet"},{"issue":"8","key":"1728_CR18","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41588-021-00892-1","volume":"53","author":"AR Barton","year":"2021","unstructured":"Barton AR, Sherman MA, Mukamel RE, Loh PR. Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses. Nat Genet. 2021;53(8):1260\u20139.","journal-title":"Nat Genet"},{"issue":"10","key":"1728_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415\u201324.","journal-title":"Nat Genet"},{"issue":"5","key":"1728_CR20","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","volume":"182","author":"MH Chen","year":"2020","unstructured":"Chen MH, Raffield LM, Mousas A, et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell. 2020;182(5):1198-1213.e14.","journal-title":"Cell"},{"issue":"5","key":"1728_CR21","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","volume":"182","author":"MH Chen","year":"2020","unstructured":"Chen MH, Raffield LM, Mousas A, et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell. 2020;182(5):1198-1213.e14.","journal-title":"Cell"},{"issue":"7952","key":"1728_CR22","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1038\/s41586-023-05837-8","volume":"615","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;615(7952):E19.","journal-title":"Nature."},{"issue":"5","key":"1728_CR23","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ije\/dyw088","volume":"45","author":"DI Swerdlow","year":"2016","unstructured":"Swerdlow DI, Kuchenbaecker KB, Shah S, et al. Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol. 2016;45(5):1600\u201316.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"1728_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2337\/db22-0110","volume":"72","author":"V Garfield","year":"2023","unstructured":"Garfield V, Salzmann A, Burgess S, et al. A guide for selection of genetic instruments in mendelian randomization studies of type 2 diabetes and HbA1c: toward an integrated approach. Diabetes. 2023;72(2):175\u201383.","journal-title":"Diabetes"},{"issue":"1","key":"1728_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3892\/ijo.2023.5526","volume":"63","author":"A Tsatsakis","year":"2023","unstructured":"Tsatsakis A, Oikonomopoulou T, Nikolouzakis TK, et al. Role of telomere length in human carcinogenesis (Review). Int J Oncol. 2023;63(1):639.","journal-title":"Int J Oncol."},{"key":"1728_CR26","doi-asserted-by":"publisher","first-page":"583106","DOI":"10.3389\/fgene.2020.583106","volume":"11","author":"Y Gao","year":"2020","unstructured":"Gao Y, Wei Y, Zhou X, et al. Assessing the relationship between leukocyte telomere length and cancer risk\/mortality in UK biobank and TCGA datasets with the genetic risk score and mendelian randomization approaches. Front Genet. 2020;11:583106.","journal-title":"Front Genet"},{"issue":"12","key":"1728_CR27","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1002\/ijc.28934","volume":"135","author":"FS Hosnijeh","year":"2014","unstructured":"Hosnijeh FS, Matullo G, Russo A, et al. Prediagnostic telomere length and risk of B-cell lymphoma-results from the EPIC cohort study. Int J Cancer. 2014;135(12):2910\u20137.","journal-title":"Int J Cancer"},{"issue":"4","key":"1728_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1600-0609.2007.00817.x","volume":"78","author":"SH Walsh","year":"2007","unstructured":"Walsh SH, Grabowski P, Berglund M, et al. Telomere length and correlation with histopathogenesis in B-cell leukemias\/lymphomas. Eur J Haematol. 2007;78(4):283\u20139.","journal-title":"Eur J Haematol"},{"issue":"23","key":"1728_CR29","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1158\/1078-0432.CCR-09-0845","volume":"15","author":"Q Lan","year":"2009","unstructured":"Lan Q, Cawthon R, Shen M, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 2009;15(23):7429\u201333.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1728_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41408-021-00462-y","volume":"11","author":"M Giaccherini","year":"2021","unstructured":"Giaccherini M, Macauda A, Orciuolo E, et al. Genetically determined telomere length and multiple myeloma risk and outcome. Blood Cancer J. 2021;11(4):74.","journal-title":"Blood Cancer J"},{"issue":"1","key":"1728_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s43141-023-00504-x","volume":"21","author":"AA Kalal","year":"2023","unstructured":"Kalal AA, Shetty RA, Manjappa AB, et al. Prognostic significance of dysregulation of shelterin complex and its correlation with telomere length and cytogenetics in multiple myeloma. J Genet Eng Biotechnol. 2023;21(1):50.","journal-title":"J Genet Eng Biotechnol"},{"key":"1728_CR32","doi-asserted-by":"publisher","first-page":"612665","DOI":"10.3389\/fonc.2020.612665","volume":"10","author":"BMC Jebaraj","year":"2020","unstructured":"Jebaraj BMC, Stilgenbauer S. Telomere dysfunction in chronic lymphocytic leukemia. Front Oncol. 2020;10:612665.","journal-title":"Front Oncol"},{"key":"1728_CR33","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.2147\/OTT.S198313","volume":"12","author":"B Wysoczanska","year":"2019","unstructured":"Wysoczanska B, Dratwa M, Gebura K, et al. Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia. Onco Targets Ther. 2019;12:4309\u201320.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"1728_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-016-0293-y","volume":"9","author":"G Caocci","year":"2016","unstructured":"Caocci G, Greco M, Delogu G, et al. Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients. J Hematol Oncol. 2016;9(1):63.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1728_CR35","first-page":"1515","volume":"19","author":"E Eskandari","year":"2018","unstructured":"Eskandari E, Hashemi M, Naderi M, et al. Leukocyte telomere length shortening, hTERT genetic polymorphisms and risk of childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2018;19(6):1515\u201321.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"20","key":"1728_CR36","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1093\/hmg\/ddad126","volume":"32","author":"SM Sullivan","year":"2023","unstructured":"Sullivan SM, Cole B, Lane J, et al. Predicted leukocyte telomere length and risk of myeloid neoplasms. Hum Mol Genet. 2023;32(20):2996\u20133005.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1728_CR37","doi-asserted-by":"publisher","first-page":"23301","DOI":"10.1038\/s41598-021-02767-1","volume":"11","author":"M Dratwa","year":"2021","unstructured":"Dratwa M, Wysocza\u0144ska B, Butrym A, et al. TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia. Sci Rep. 2021;11(1):23301.","journal-title":"Sci Rep"},{"issue":"18","key":"1728_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1172\/JCI147598","volume":"131","author":"KE Schratz","year":"2021","unstructured":"Schratz KE, Gaysinskaya V, Cosner ZL, et al. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders. J Clin Invest. 2021;131(18):63.","journal-title":"J Clin Invest."},{"issue":"3","key":"1728_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamainternmed.2021.7804","volume":"182","author":"CV Schneider","year":"2022","unstructured":"Schneider CV, Schneider KM, Teumer A, et al. Association of telomere length with risk of disease and mortality. JAMA Intern Med. 2022;182(3):291\u2013300.","journal-title":"JAMA Intern Med"},{"issue":"14","key":"1728_CR40","doi-asserted-by":"publisher","first-page":"eabl6579","DOI":"10.1126\/sciadv.abl6579","volume":"8","author":"T Nakao","year":"2022","unstructured":"Nakao T, Bick AG, Taub MA, et al. Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential. Sci Adv. 2022;8(14):eabl6579.","journal-title":"Sci Adv."},{"issue":"8","key":"1728_CR41","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","volume":"54","author":"SP Kar","year":"2022","unstructured":"Kar SP, Quiros PM, Gu M, et al. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat Genet. 2022;54(8):1155\u201366.","journal-title":"Nat Genet"},{"issue":"8","key":"1728_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/biomedicines10082027","volume":"10","author":"TB Opstad","year":"2022","unstructured":"Opstad TB, Solheim S, Pettersen AR, et al. TERT and TET2 genetic variants affect leukocyte telomere length and clinical outcome in coronary artery disease patients-a possible link to clonal hematopoiesis. Biomedicines. 2022;10(8):63.","journal-title":"Biomedicines."},{"issue":"4","key":"1728_CR43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1101\/gr.157529.113","volume":"24","author":"S Maegawa","year":"2014","unstructured":"Maegawa S, Gough SM, Watanabe-Okochi N, et al. Age-related epigenetic drift in the pathogenesis of MDS and AML. Genome Res. 2014;24(4):580\u201391.","journal-title":"Genome Res"},{"issue":"1","key":"1728_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13148-023-01496-8","volume":"15","author":"DR Nannini","year":"2023","unstructured":"Nannini DR, Cortese R, Egwom P, et al. Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age. Clin Epigenetics. 2023;15(1):81.","journal-title":"Clin Epigenetics"},{"issue":"19","key":"1728_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/cells12192392","volume":"12","author":"A Allegra","year":"2023","unstructured":"Allegra A, Caserta S, Mirabile G, et al. Aging and age-related epigenetic drift in the pathogenesis of leukemia and lymphomas: new therapeutic targets. Cells. 2023;12(19):63.","journal-title":"Cells."},{"key":"1728_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijsu.2019.11.004","volume":"72","author":"L Tang","year":"2019","unstructured":"Tang L, Ruan Z, Zhao S. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: a systematic review and meta-analysis. Int J Surg. 2019;72:206\u201313.\u00a0","journal-title":"Int J Surg"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01728-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-024-01728-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01728-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T18:03:20Z","timestamp":1724781800000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-024-01728-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1728"],"URL":"https:\/\/doi.org\/10.1186\/s13148-024-01728-5","relation":{},"ISSN":["1868-7083"],"issn-type":[{"type":"electronic","value":"1868-7083"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"120"}}